Ailing Gui

Hexokinase II expression as a prognostic marker in diffuse large B-cell lymphoma: pre- and post-rituximab era

Junjie Cao, F. Lv, X. Hong, 2022, International Journal of Hematology.

MORTALIN-Ca2+ axis drives innate rituximab resistance in diffuse large B-cell lymphoma.

S. Qiu, J. Zuo, Ling Yang, 2022, Cancer letters.

Hexokinase II expression as a prognostic marker in diffuse large B-cell lymphoma: pre- and post-rituximab era

Junjie Cao, F. Lv, X. Hong, 2022, International Journal of Hematology.

A Regulatory Loop Involving miR-200c and NF-κB Modulates Mortalin Expression and Increases Cisplatin Sensitivity in an Ovarian Cancer Cell Line Model

S. Qiu, J. Zuo, Ling Yang, 2022, International journal of molecular sciences.

Serum miR‐146a level is a potential biomarker in predicting the outcome of diffuse large B‐cell lymphoma

J. Zuo, Ling Yang, Wen Liu, 2022, Asia-Pacific journal of clinical oncology.

Contactin‐6‐deficient male mice exhibit the abnormal function of the accessory olfactory system and impaired reproductive behavior

Haihong Ye, Zhicheng Xiao, Tian Zhao, 2023, Brain and behavior.

Deubiquitinase OTUD7B is a potential prognostic biomarker in diffuse large B-cell lymphoma

S. Qiu, J. Zuo, Ling Yang, 2022, Journal of Cancer.